Immunovant, Inc. Common Stock (NASDAQ: IMVT) last traded at $44.37, up 0.05% on the session. The quote above updates while this page is open; the figures below are drawn from Immunovant, Inc. Common Stock’s own filings and are restated only when a new one is published.
Immunovant, Inc. Common Stock trades on NASDAQ under the ticker IMVT. Its market capitalisation is $9.16 billion.
Valuation measures for Immunovant, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.16B |
|---|---|
| Enterprise value | $8.48B |
| Price / book | 12.46 |
| Beta | 1.34 |
Trailing-twelve-month figures tagged in Immunovant, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$538.22M |
|---|---|
| EPS (TTM) | -$2.81 |
| Return on equity | -73.19% |
| Cash | $797.80M |
Range and volume for IMVT over the past 52 weeks.
| 52-week high | $45.42 |
|---|---|
| 52-week low | $14.47 |
| Volume | 836.4K |
| Average volume | 1.34M |
| Previous close | $44.35 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.